- Home
- Â /Â Quest Diagnostics
Quest Diagnostics
Stock Price
$156
2024-10-29
Market Capitalization
$17.4 B
2024-10-29
Revenue
$9.9 B
FY, 2024
Quest Diagnostics Summary
Company Summary
- Overview
- Quest Diagnostics is a company that provides diagnostic information services. It offers routine, clinical, and anatomic pathology laboratory testing, data capture and imaging, medical support, risk assessment, paramedical examinations, and other services.
- Type
- Public
- Status
- Active
- Founded
- 1967
- HQ
- Secaucus, NJ, US | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Sam Samad, Executive Vice President and Chief Financial Officer
Michael E. Prevoznik, Senior Vice President and General Counsel
Cecilia McKenney, Senior Vice President and Chief Human Resources Officer
Operating MetricsView all
Facilities Leased
9
10.0%
FY, 2023
Facilities Owned
6
FY, 2023
Volume (Government Payers), percent
10.0%
FY, 2023
LocationsView all
5 locations detected
Secaucus, NJÂ HQ
United States
500 Plaza Dr
São Paulo, SP
Brazil
Rua Barão do Triunfo, 88 salas 1614-1615 Brooklin Paulista
Hyderabad, TS
India
Level 2, Building No. H06A, Avance Business Hub Behind Dell Campus, Gachibowli
Dublin, D
Ireland
Unit 20, Northwood House, Santry
Ciudad de México, CDMX
Mexico
Montecito 38-piso. 38, piso 9, Nápoles, Benito Juárez
Quest Diagnostics Financials
Summary Financials
- Revenue (Q1, 2025)
- $2.7B
- Gross profit (Q1, 2025)
- $863.0M
- Net income (Q1, 2025)
- $235.0M
- Cash (Q1, 2025)
- $188.0M
- EBIT (Q1, 2025)
- $346.0M
- Enterprise value
- $23.1B